Table 1.
Patient and tumor characteristics.
| Characteristics | Overall (n = 125) |
|---|---|
| Age (years), median (IQR) | 73 (67-78) |
| Age-adjusted CCI score | |
| 1 | 4 (3.2) |
| 2 | 27 (21.6) |
| 3 | 22 (17.6) |
| 4 | 33 (26.4) |
| 5 | 33 (26.4) |
| 6 | 6 (4.8) |
| NCCN risk groups | |
| High | 90 (72.0) |
| Very high | 35 (28.0) |
| PSA level (ng/mL), median (IQR) | 27.8 (21.2-60.5) |
| Body composition at baseline | |
| BMI (kg/m2) | 24.2 ± 3.5 |
| SMI (cm2/m2) | 47.2 ± 7.4 |
| Sarcopeniaa | 42 (33.6) |
| SMD (HU) | 37.8 ± 5.6 |
| SATI (cm2/m2) | 39.9 ± 13.6 |
| VATI (cm2/m2) | 55.2 ± 28.0 |
| TATI (cm2/m2) | 95.1 ± 37.7 |
| Median (IQR) duration between CT scans, days | 180 (146-223) |
BMI, body mass index; CCI, Charlson Comorbidity Index; CT, computed tomography; HU, Hounsfield unit; IQR, interquartile range; NCCN, National Comprehensive Cancer Network; SMD, skeletal muscle radiodensity; SMI, skeletal muscle index; SATI, subcutaneous adipose tissue index; TATI, total adipose tissue index; VATI, visceral adipose tissue index.
Data are mean ± standard error or number (%).
a
SMI<43.2 cm2/m2 were defined as sarcopenia.